Dufresne, A., et al.. Added-value of Whole Exome and RNA Sequencing in Advanced and Refractory Cancer Patients with No Molecular-based Treatment Recommendation Based on a 90-gene Panel. Cold Spring Harbor Laboratory, 10 Feb. 2022, doi:10.1101/2022.02.08.22270301.